On information organization and information extraction for the study of gene expressions by tissue microarray technique
暂无分享,去创建一个
[1] David J. Foran,et al. A prototype for unsupervised analysis of tissue microarrays for cancer research and diagnostics , 2004, IEEE Transactions on Information Technology in Biomedicine.
[2] T. Barrette,et al. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. , 2002, Cancer research.
[3] Jules J. Berman,et al. The tissue microarray data exchange specification: A community-based, open source tool for sharing tissue microarray data , 2003, BMC Medical Informatics Decis. Mak..
[4] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[6] Richard A. Johnson,et al. Applied Multivariate Statistical Analysis , 1983 .
[7] S. Dudoit,et al. Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data , 2002 .
[8] Manish Parashar,et al. Engineering a peer-to-peer collaboratory for tissue microarray research , 2004, Proceedings of the Second International Workshop on Challenges of Large Applications in Distributed Environments, 2004. CLADE 2004..
[9] F. Demichelis,et al. The virtual case: a new method to completely digitize cytological and histological slides , 2002, Virchows Archiv.
[10] A. D. Dei Tos,et al. Cyclin D3 expression in normal, reactive and neoplastic tissues , 1998, The Journal of pathology.
[11] Greg Yothers,et al. Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience. , 2002, Journal of the National Cancer Institute.
[12] P. Brown,et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[13] T. Barrette,et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.
[14] O. Kallioniemi,et al. Tissue microarray technology for high-throughput molecular profiling of cancer. , 2001, Human molecular genetics.
[15] Axel Hoos,et al. Tissue Microarray Profiling of Cancer Specimens and Cell Lines: Opportunities and Limitations , 2001, Laboratory Investigation.
[16] E. F. Codd,et al. The Relational Model for Database Management, Version 2 , 1990 .
[17] Ross Ihaka,et al. Gentleman R: R: A language for data analysis and graphics , 1996 .
[18] Lin Yang,et al. Novel relational database for tissue microarray analysis. , 2009, Archives of pathology & laboratory medicine.
[19] Kenneth A. Fleming,et al. EDITORIAL. EVIDENCE‐BASED PATHOLOGY , 1996 .
[20] R. Tibshirani,et al. Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data , 2004, PLoS biology.
[21] Partha S. Vasisht. Computational Analysis of Microarray Data , 2003 .
[22] Manuel Salto-Tellez,et al. Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays. , 2003, Human pathology.
[23] Ash A. Alizadeh,et al. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. , 2002, The American journal of pathology.
[24] Michael I. Jordan,et al. Robust Sparse Hyperplane Classifiers: Application to Uncertain Molecular Profiling Data , 2004, J. Comput. Biol..
[25] P. Park. Gene Expression Data and Survival Analysis , 2005 .
[26] G. Viale,et al. p63, a p53 Homologue, Is a Selective Nuclear Marker of Myoepithelial Cells of the Human Breast , 2001, The American journal of surgical pathology.
[27] Pat Langley,et al. An Analysis of Bayesian Classifiers , 1992, AAAI.
[28] R. Tibshirani,et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[29] Krzysztof J. Cios,et al. Uniqueness of medical data mining , 2002, Artif. Intell. Medicine.
[30] F. Harrell,et al. Regression modelling strategies for improved prognostic prediction. , 1984, Statistics in medicine.
[31] Wray L. Buntine. Operations for Learning with Graphical Models , 1994, J. Artif. Intell. Res..
[32] D. Rimm,et al. Automated subcellular localization and quantification of protein expression in tissue microarrays , 2002, Nature Medicine.
[33] Paola Sebastiani,et al. Statistical Challenges in Functional Genomics , 2003 .
[34] Arul M Chinnaiyan,et al. Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. , 2003, Journal of the National Cancer Institute.
[35] H. Moch,et al. Tissue microarray (TMA) technology: miniaturized pathology archives for high‐throughput in situ studies , 2001, The Journal of pathology.
[36] K. Fleming,et al. Evidence-based pathology , 1997, Evidence Based Medicine.
[37] M. Rubin,et al. Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model. , 2001, The American journal of pathology.
[38] David B. Dunson,et al. Bayesian Data Analysis , 2010 .
[39] Daniel B. Martin,et al. Quantitative Proteomic Analysis of Proteins Released by Neoplastic Prostate Epithelium , 2004, Cancer Research.
[40] A. Sboner,et al. Large scale TMA experiments : automation and data management , 2004 .
[41] Lu Tian,et al. Linking gene expression data with patient survival times using partial least squares , 2002, ISMB.
[42] N M Luscombe,et al. What is Bioinformatics? A Proposed Definition and Overview of the Field , 2001, Methods of Information in Medicine.
[43] C. Li,et al. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[44] Kimberly F. Johnson. Methods of Microarray Data Analysis II , 2002, Springer US.
[45] Mark A. Rubin,et al. Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements. , 2004, The American journal of pathology.
[46] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[47] E Mahlamäki,et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. , 1999, Journal of the National Cancer Institute.
[48] M. Rubin,et al. Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men. , 2000, Journal of the National Cancer Institute.
[49] D. Rimm,et al. Validation of Tissue Microarray Technology in Breast Carcinoma , 2000, Laboratory Investigation.
[50] John T. Wei,et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. , 2005, Cancer cell.
[51] Padhraic Smyth,et al. From Data Mining to Knowledge Discovery: An Overview , 1996, Advances in Knowledge Discovery and Data Mining.
[52] E. Devilard,et al. Identification of TCL1A as an immunohistochemical marker of adverse outcome in diffuse large B-cell lymphomas. , 2005, International journal of oncology.
[53] D G Altman,et al. Survival Analysis Part IV: Further concepts and methods in survival analysis , 2003, British Journal of Cancer.
[54] W. Sellers,et al. Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer , 2004, Cancer Research.
[55] M. Rubin,et al. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. , 2000, Human pathology.
[56] Stephen M. Hewitt,et al. Post-analysis follow-up and validation of microarray experiments , 2002, Nature Genetics.
[57] P. Brown,et al. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[58] S. Varambally,et al. JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence , 2004, Cancer Research.
[59] Ivar Jacobson,et al. The Unified Software Development Process , 1999 .
[60] D. Slamon,et al. Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins. , 2001, The American journal of pathology.
[61] H. Moch,et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. , 1999, The American journal of pathology.
[62] Michael W Kattan,et al. Judging new markers by their ability to improve predictive accuracy. , 2003, Journal of the National Cancer Institute.
[63] S. Fox,et al. Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. , 1996, Human pathology.
[64] Nada Lavrac,et al. Selected techniques for data mining in medicine , 1999, Artif. Intell. Medicine.
[65] S. Dhanasekaran,et al. Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.
[66] D.,et al. Regression Models and Life-Tables , 2022 .
[67] I. Shih. The role of CD146 (Mel‐CAM) in biology and pathology , 1999, The Journal of pathology.
[68] Ronald Simon,et al. Tissue microarray (TMA) applications: implications for molecular medicine , 2003, Expert Reviews in Molecular Medicine.
[69] A. Tversky,et al. Judgment under Uncertainty: Heuristics and Biases , 1974, Science.
[70] A. Le Bivic,et al. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. , 2001, Blood.
[71] Jun Chen,et al. Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes , 2004, BMC Bioinformatics.
[72] K. Pienta,et al. Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[73] Nicholas I. Fisher,et al. Bump hunting in high-dimensional data , 1999, Stat. Comput..
[74] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[75] Leo Breiman,et al. Classification and Regression Trees , 1984 .
[76] W. Gerald,et al. Gene expression profiling predicts clinical outcome of prostate cancer. , 2004, The Journal of clinical investigation.
[77] K. Pienta,et al. Tissue Microarray Sampling Strategy for Prostate Cancer Biomarker Analysis , 2002, The American journal of surgical pathology.
[78] Xueli Liu,et al. Statistical Methods for Analyzing Tissue Microarray Data , 2004, Journal of biopharmaceutical statistics.
[79] D L Rimm,et al. Amplification of tissue by construction of tissue microarrays. , 2001, Experimental and molecular pathology.
[80] Jiang Gui,et al. Partial Cox regression analysis for high-dimensional microarray gene expression data , 2004, ISMB/ECCB.
[81] H. Moch,et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. , 2001, The American journal of pathology.
[82] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[83] Mark A Rubin,et al. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens. , 2004, Human pathology.
[84] H. Battifora. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[85] Anil K. Jain,et al. Data clustering: a review , 1999, CSUR.
[86] Stefano Forti,et al. Digital Pathology: Science Fiction? , 2000, International journal of surgical pathology.
[87] John McCafferty,et al. Expression profiling by high-throughput immunohistochemistry. , 2004, Journal of immunological methods.
[88] G. Parmigiani,et al. Web-based tissue microarray image data analysis: initial validation testing through prostate cancer Gleason grading. , 2001, Human pathology.
[89] B. Stein,et al. Immunoperoxidase localization of prostatic antigens. Comparison of primary and metastatic sites. , 1984, Urology.
[90] Thomas G. Dietterich. What is machine learning? , 2020, Archives of Disease in Childhood.
[91] J. Welsh,et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.
[92] R. Verhaak,et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. , 2004, The New England journal of medicine.